Milestone Pharmaceuticals (MIST)
(Delayed Data from NSDQ)
$1.74 USD
-0.01 (-0.57%)
Updated May 17, 2024 04:00 PM ET
After-Market: $1.73 -0.01 (-0.57%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth B Momentum F VGM
Brokerage Reports
Milestone Pharmaceuticals Inc. [MIST]
Reports for Purchase
Showing records 21 - 25 ( 25 total )
Company: Milestone Pharmaceuticals Inc.
Industry: Medical - Biomedical and Genetics
Company: Milestone Pharmaceuticals Inc.
Industry: Medical - Biomedical and Genetics
2Q21 Results; Lead Program Etripamil on Track to Generate Pivotal Phase 3 Data in 2H22
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Milestone Pharmaceuticals Inc.
Industry: Medical - Biomedical and Genetics
1Q21 Results; Pipeline Progressing With RAPID Top-Line Data Expected 2H22; China Collaboration Announced
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Milestone Pharmaceuticals Inc.
Industry: Medical - Biomedical and Genetics
Etripamil Program on Track; Complete Survey Results Highlight Blockbuster Potential; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Milestone Pharmaceuticals Inc.
Industry: Medical - Biomedical and Genetics
Dancing to the Beat of its Own Heart; Initiating With a Buy and $20 Price Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P